CMG Pharmaceutical Co., Ltd. (KOSDAQ:058820)
South Korea
· Delayed Price · Currency is KRW 1,795.00
+5.00 (0.28%)
Apr 29, 2026, 2:50 PM KST
CMG Pharmaceutical Revenue
In the year 2025, CMG Pharmaceutical had annual revenue of 105.23B KRW with 6.19% growth. CMG Pharmaceutical had revenue of 31.53B in the quarter ending December 31, 2025, with 18.02% growth.
Revenue
105.23B
Revenue Growth
+6.19%
P/S Ratio
2.51
Revenue / Employee
471.88M
Employees
223
Market Cap
264.64B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 105.23B | 6.13B | 6.19% |
| Dec 31, 2024 | 99.10B | 5.19B | 5.53% |
| Dec 31, 2023 | 93.91B | 11.71B | 14.25% |
| Dec 31, 2022 | 82.20B | 23.57B | 40.21% |
| Dec 31, 2019 | 58.62B | 8.76B | 17.56% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BNC Korea | 95.90B |
| Korea United Pharm | 161.44B |
| HLB Pharmaceutical | 205.58B |
| JW Holdings | 969.57B |
| Boditech Med | 162.09B |
| Chong Kun Dang Holdings | 959.01B |
| Hyundai Pharmaceutical | 108.14B |
| Daewon Pharmaceutical | 605.43B |